Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 1,885 put options on the stock. This represents an increase of 1,101% compared to the typical volume of 157 put options.
Evelo Biosciences Price Performance
EVLO stock opened at $0.00 on Thursday. The company has a market capitalization of $9,420.00, a PE ratio of 0.00 and a beta of 0.68. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $0.00.
Evelo Biosciences Company Profile
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Featured Articles
- Five stocks we like better than Evelo Biosciences
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
